Competent authorities prepare foe medtech policy discussions in Slovenia:
This article was originally published in Clinica
The next meeting of medical device experts from the competent authorities of the EU is due to take place in Brdo, Slovenia, on February 25-26. This is being organised in the context of the rotating presidency of the EU, which is currently held by Slovenia. At the meeting, experts from the national authorities of the EU, candidate countries, EFTA and the European Commission will discuss overall medical device policy issues.
You may also be interested in...
A reagent in a batch of COVID-19 tests shipped by the US Centers for Disease Control and Prevention to state laboratories “wasn’t performing consistently,” a top CDC official says, so the agency is reformulating it – slowing down the labs’ ability to use the diagnostic, which yielded inconsistent results when quality-tested. But waiting in the wings are commercial coronavirus test kits being developed by Qiagen and Cepheid; both firms say they’ll submit the kits to the FDA for emergency-use approval.
OIG will focus on successful drugs that have been repurposed as orphans, noting nine of the 10 top selling drugs have both orphan and non-orphan indications.
Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.